Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Definitive Healthcare (DH) EBITDA Margin (2020 - 2026)

Definitive Healthcare filings provide 6 years of EBITDA Margin readings, the most recent being 43.27% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 11657.0% to 43.27% in Q4 2025 year-over-year; TTM through Dec 2025 was 92.86%, a 18899.0% increase, with the full-year FY2025 number at 92.86%, up 18899.0% from a year prior.
  • EBITDA Margin hit 43.27% in Q4 2025 for Definitive Healthcare, down from 14.47% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 6.86% in Q2 2025 to a low of 579.95% in Q2 2024.
  • Median EBITDA Margin over the past 5 years was 21.25% (2022), compared with a mean of 107.65%.
  • Biggest five-year swings in EBITDA Margin: tumbled -56014bps in 2024 and later soared 57308bps in 2025.
  • Definitive Healthcare's EBITDA Margin stood at 28.28% in 2021, then skyrocketed by 39bps to 17.39% in 2022, then rose by 12bps to 15.29% in 2023, then tumbled by -946bps to 159.84% in 2024, then surged by 73bps to 43.27% in 2025.
  • The last three reported values for EBITDA Margin were 43.27% (Q4 2025), 14.47% (Q3 2025), and 6.86% (Q2 2025) per Business Quant data.